Skip to main content

Table 1 Patients characteristics

From: Long-term respiratory follow-up of H1N1 infection

  Upon admission Upon Discharge
Characteristic H1N1(+) Mean Range (±SD) Mean Range (±SD)
Age (years) 36 14-65 (14.7)    
Male/Female (n, %) 28/16 (63.6%/36.3%)    
Smokers       
(male/female) (n, %) 8/28 (28.6%) and 3/16 (18.8%)    
Non-Smokers       
(male/female) 20/28 (71.4%) and 13/16 (81.3%)    
BMI 30.23 20-45 (8.757)    
No,pts with obesity (male/female) 7/28 (25%) and 4/16 (25%)    
No.pts without obesity (male/female) 21/28 (75%) and 12/16 (75%)    
Co-exististing conditions (n, %)
Asthma 15/44 (34%)      
COPD 6/44 (13.6%)      
IPF 1/44 (2.2%)      
Lymphoma 5/44 (11.3%)      
Diabetes 8/44 (18.1%)      
Coronary Heart Disease 10/44 (22.7%)      
Outcomes-days       
   Duration of fever in hospital under treatment 2.45 1-4 (0.875)    
   Days of Hospitalization 5.39 3-12 (1.781)    
   Days under oseltamivir regimen 5.25 4-10 (1.014)    
Adverse events (n, %)       
Abnormal liver function 7/44 (15.9%)    
Nausea, Diarrhea 4.5%      
Vomiting 1.4%      
Hypoxemia 1/44 (21.2%)      
CRP 5.18 0.26-17.38 (5.123) 1.33 0.16-4.53 (1.01)
WBC 7.114 3.340-10.950 (2172.160) 6.806 3340-10950 (2021.6)
Fever 39.06 37-40 (0.834) 37.8 36.3-39.2 (0.77)
CR 0.9 0.5-1.30 (0.17) 0.8 5-1 (0.12)
UR 26.18 11-41 (7.469) 25.11 12-40 (7.127)
SGPT 24.48 10-138 (26.37) 27.80 9-136 (26.719)
SGOT 27.09 14-125 (22.941) 24.14 9-57 (12.22)
Spo2 (FiO2 21%) 96.07 89-99 (2.3) 96.98 94-99 (1.248)
PO2 (FiO221%) 81.23 53-113 (14.586) 87.66 67-113 (12.473)
Abnormalities on chest radiograph (n, %)       
Local patchy shadowing 8/44 (18.1%) 6/44 (13.6%)
Ground-glass opacities 3/44 (6.8%) 2/44 (4.5%)
Interstitial abnormality 1/44 (2.2%) 1/44 (2.2%)